Outcomes of tracheostomies performed in COVID-19 positive patients at Hospital Central del Estado Chihuahua, Mexico.

IF 0.5 4区医学 Q4 SURGERY Cirugia Y Cirujanos Pub Date : 2023-01-01 DOI:10.24875/CIRU.20001342

Irving A Aponte-De la Rosa, Ma Isabel Saad-Manzanera, Jesús Solís-Valdez, Luis B Enríquez-Sánchez, Margarita A Fabela-Lozano, Javier A Guevara-López

{"title":"Outcomes of tracheostomies performed in COVID-19 positive patients at Hospital Central del Estado Chihuahua, Mexico.","authors":"Irving A Aponte-De la Rosa, Ma Isabel Saad-Manzanera, Jesús Solís-Valdez, Luis B Enríquez-Sánchez, Margarita A Fabela-Lozano, Javier A Guevara-López","doi":"10.24875/CIRU.20001342","DOIUrl":null,"url":null,"abstract":"Objective: Provide a description of clinical characteristics, associated factors and outcome of tracheostomies performed in COVID-19 patients.Method: Observational prospective study of 14 patients who underwent tracheostomy. 10 of them were diagnosed with COVID 19, confirmed with RT-PCR test of nasopharyngeal exudate and compatible tomographic findings.Results: Of the 10 patients, five were discharged and five died. The average age of patients who died was 66.6 years; of those who were discharged, it was 60.4 years. Ventilatory parameters cut was taken as FiO2 ≤ 40% and PEEP ≤ 8; of the patients discharged, four met both criteria. On the other hand, of the patients who died, neither met both. Of the latter, an average of APACHE II of 16.4 and SOFA 7.4 were documented, while in discharged patients an average of 12.6 and 4.6 were observed, respectively.Conclusions: Tracheostomy performed in patients with specific criteria, such as low ventilatory parameters, age, or low score in severity scales, may have a better prognosis.","PeriodicalId":50990,"journal":{"name":"Cirugia Y Cirujanos","volume":"91 2","pages":"253-261"},"PeriodicalIF":0.5000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cirugia Y Cirujanos","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.24875/CIRU.20001342","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: Provide a description of clinical characteristics, associated factors and outcome of tracheostomies performed in COVID-19 patients.

Method: Observational prospective study of 14 patients who underwent tracheostomy. 10 of them were diagnosed with COVID 19, confirmed with RT-PCR test of nasopharyngeal exudate and compatible tomographic findings.

Results: Of the 10 patients, five were discharged and five died. The average age of patients who died was 66.6 years; of those who were discharged, it was 60.4 years. Ventilatory parameters cut was taken as FiO₂ ≤ 40% and PEEP ≤ 8; of the patients discharged, four met both criteria. On the other hand, of the patients who died, neither met both. Of the latter, an average of APACHE II of 16.4 and SOFA 7.4 were documented, while in discharged patients an average of 12.6 and 4.6 were observed, respectively.

Conclusions: Tracheostomy performed in patients with specific criteria, such as low ventilatory parameters, age, or low score in severity scales, may have a better prognosis.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

墨西哥奇瓦瓦州中央医院COVID-19阳性患者气管切开术的结果

目的:分析新冠肺炎患者气管切开术的临床特点、相关因素及预后。方法:对14例气管切开术患者进行观察性前瞻性研究。其中10例确诊为新冠肺炎，经鼻咽渗出液RT-PCR检测和吻合的体层扫描结果证实。结果:10例患者中，5例出院，5例死亡。死亡患者的平均年龄为66.6岁;在那些被解雇的人中，寿命为60.4年。取通气参数cut为FiO2≤40%，PEEP≤8;在出院的患者中，有4人同时符合这两个标准。另一方面，在死亡的病人中，没有人满足这两个要求。在后者中，平均APACHE II为16.4,SOFA为7.4，而在出院患者中，平均APACHE II为12.6,SOFA为4.6。结论:气管切开术患者具有特定的标准，如低通气参数，年龄，或低严重程度评分，可能有更好的预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Cirugia Y Cirujanos 医学-外科

CiteScore

0.90

自引率

20.00%

发文量

207

审稿时长

6-12 weeks

期刊介绍： Cirugía y Cirujanoses exponente del desarrollo académico, científico, médico, quirúrgico y tecnológico en materia de salud en México y en el ámbito internacional. Es una revista bimestral, open access, revisada por pares, que publica en español y en inglés (traducido sin coste para los autores) artículos científicos originales, casos clínicos, artículos de revisión de interés general y cartas al editor. Los artículos se seleccionan y publican siguiendo un riguroso análisis, de acuerdo con los estándares internacionalmente aceptados. Sus espacios están abiertos a los académicos, así como a todo miembro de la comunidad médica que manifieste interés por utilizar este foro para publicar sus trabajos.